Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Bicalutamide CAS 90357-06-5 High-Quality Supplier and Manufacturer Information

Dec . 26, 2024 08:53 Back to list

Bicalutamide CAS 90357-06-5 High-Quality Supplier and Manufacturer Information



An Overview of Bicalutamide Its CAS Number, Suppliers, and Applications


Bicalutamide, known by its CAS number 90357-06-5, is a non-steroidal anti-androgen medication primarily used in the treatment of prostate cancer. It exerts its effects by binding to androgen receptors, thus inhibiting the action of androgens such as testosterone. This mechanism makes bicalutamide an essential component of hormone therapy for managing advanced forms of prostate cancer.


Clinical Applications


Bicalutamide is often administered in conjunction with other therapeutic agents, particularly in cases where surgical options are not viable or have been exhausted. Often used as an adjunct therapy to luteinizing hormone-releasing hormone (LHRH) agonists, bicalutamide helps reduce the levels of circulating testosterone, thereby slowing the progression of hormone-sensitive tumors. In addition to prostate cancer, bicalutamide has also been explored for other conditions, like male pattern hair loss and certain benign conditions related to androgen excess.


Mechanism of Action


As a potent and selective androgen receptor antagonist, bicalutamide works by preventing androgens from binding to their receptors on the target cancer cells. This blockade interrupts the signaling pathways that promote tumor growth and proliferation. The drug's pharmacological profile allows it to effectively reduce tumor size and progression, offering a crucial treatment option for patients diagnosed with advanced prostate cancer.


Suppliers of Bicalutamide


bicalutamide cas 90357-06-5 supplier

bicalutamide cas 90357-06-5 supplier

The demand for bicalutamide has led to a proliferation of suppliers and manufacturers across the globe. Choosing a reliable supplier is essential for healthcare providers and pharmaceutical companies due to the drug's significant implications for health. Suppliers often provide bicalutamide in various forms, including tablets and injections, meeting diverse patient needs.


Global pharmaceutical companies, as well as specialized chemical suppliers, often produce bicalutamide for various markets. When sourcing bicalutamide, potential buyers should consider suppliers that adhere to Good Manufacturing Practices (GMP), ensuring the drug's purity, potency, and safety. Certifications from regulatory bodies such as the FDA in the United States or EMA in Europe add an extra layer of assurance regarding the quality of the product.


Factors to Consider When Choosing a Supplier


1. Quality Assurance Verify that the supplier holds necessary certifications and follows strict manufacturing standards. 2. Price Competitiveness Compare prices from different suppliers while considering the quality of the product. 3. Reputation and Reviews Research supplier reviews, industry reputation, and customer feedback. 4. Supply Chain Reliability Ensure the supplier can meet your volume requirements and deliver on time. 5. Regulatory Compliance Confirm that the supplier complies with local and international regulations regarding pharmaceutical products.


Conclusion


Bicalutamide (CAS 90357-06-5) plays a pivotal role in the medical management of prostate cancer, improving the quality of life for patients worldwide. Its unique method of action as an androgen receptor antagonist places it at the forefront of hormonal management strategies in oncology. As demand for bicalutamide grows, the importance of selecting reliable suppliers becomes ever more critical. By prioritizing quality, reputation, and regulatory compliance, healthcare providers can ensure they are offering patients the best possible treatments available. Whether in clinical settings or research laboratories, bicalutamide maintains its status as a cornerstone in the fight against prostate cancer, contributing to more effective and targeted patient care.


For those in the pharmaceutical industry or healthcare sectors, understanding both the clinical implications and the supply landscape surrounding bicalutamide is essential for optimizing treatment outcomes and advancing cancer care.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish